Statement to the Subcommittee on Energy and Environment of the Committee on
Science, United States House of Representatives, July 18, 2000
Steve Wing, Associate Professor, Department of Epidemiology, School of
Public Health, University of North Carolina>
Mr. Chairman and Members of the Committee, thank you for inviting me to
testify about health effects of low level radiation. I am an epidemiologist
on the faculty at the University of North Carolina where I have studied
radiation health effects among workers at Oak Ridge, Los Alamos, Hanford and
Savannah River under funding from the Departments of Energy and Health and
Human Services. Epidemiology, the study of disease in human populations, is
especially important in risk estimation and standard setting because animal
and laboratory studies necessitate extrapolation from high to low doses,
from molecules and cells to organisms, and from other species to humans
(1-3).
We know that ionizing radiation can cause cancer and inherited mutations by
damaging DNA. Although epidemiologists have studied populations exposed to
both high and low levels of radiation, extrapolation of risks from high to
low doses has led to a debate over whether a straight line extrapolation, the
linear no-threshold model, is appropriate. My testimony will make three
points: current cancer risk estimates are too low by a factor of ten or more;
current standards do not adequately protect workers and the public; and, a
large and
growing body of scientific evidence shows that there is no basis for further
relaxation of radiation protection standards.
Extrapolation from high dose studies: High dose studies examine special
populations including patients receiving
radiation treatments. By far the most influential are studies of survivors
of the bombings of Hiroshima and Nagasaki that are currently the primary
basis for cancer risk estimates. However, the A-bomb studies are flawed due
to selective survival, poor dose measurement and confounding exposures (4-7).
The atomic bombings produced massive immediate casualties as well as delayed
deaths due to lingering effects of radiation, infectious epidemics, and the
destruction of food, housing, and medical services (8). Only the
healthiest survived these conditions, especially among those who are most
vulnerable, the young and the old. By 1950, when a list of survivors was
assembled for long-term study, persons most susceptible to radiation had
already died. The healthy survivor effect leads to underestimation of risks,
particularly for exposures in utero, during childhood, and at older adult
ages (6).
Detection of radiation risks depends upon the ability of an epidemiological
study to classify persons according to their exposure levels. A-bomb
survivors were not wearing radiation badges, therefore their exposures had to
be
estimated by asking survivors about their locations and shielding at the time
of detonation. In addition to the typical types of recall bias that occur
in surveys, stigmatization of survivors made some reluctant to admit their
proximity (9). Acute radiation injuries such as hair loss and burns among
survivors who reported they were at great distances from the blasts (10, 11)
suggests the magnitude of these errors, which would lead to under
estimation of radiation risks.
Another bias occurs because of the higher exposures of distant survivors to
residual radiation. Fallout affected distant survivors in both cities (8,
12). In addition, survivors who were shielded or exposed at greater distances
were strong enough to enter the areas near the hypocenters of the blasts
within hours of detonation, exposing themselves to residual radiation created
by the atomic weapons (8, 12-14). Residual radiation exposures of lower dose
survivors leads to an underestimate of radiation risks.
Direct observation from low dose studies: In 1956 Dr. Alice Stewart and
colleagues reported in The Lancet that fetal exposures during obstetric x-ray
examinations are associated with elevated childhood cancer rates (15). The
fetus is especially sensitive to radiation due to rapid cell division.
Stewart's findings have been replicated in
numerous other low dose studies (6, 16-18), and standards for medical
practice now dictate that small doses of radiation associated with a single
x-ray should be avoided during pregnancy.
Long-term studies of cancer among nuclear workers began to appear in the
1970s when Mancuso, Stewart and Kneale reported that small doses of radiation
received at older ages raised cancer rates among workers at the plutonium
production facility in Hanford, Washington (19). Manhattan Project
scientists realized in the early 1940s that workers in the weapons plants
faced special hazards, and they created a unique resource for health studies
at some facilities by issuing each employee a radiation monitor that was
incorporated into the security
badge required at work. Although dose records are poor for many workers and
veterans, long-term studies of well-monitored workers have now been reported
from nuclear facilities in the U.S., the United Kingdom and Canada. Despite
the fact that workers are generally healthy adults, many of these studies
have demonstrated
relationships between low level radiation and cancer death, particularly
among older workers. The greater sensitivity of older adults to ionizing
radiation was not recognized in A-bomb studies due to selective survival,
however this observation is consistent with studies that show reductions in
immune function and efficiency of DNA repair with aging (6, 20). Risk
estimates from many occupational studies are approximately 10 times higher
than estimates based on follow-up of A-bomb survivors (21-33), showing that
current protection standards
are too lax. In our recent study of multiple myeloma among Oak Ridge,
Hanford, Los Alamos and Savannah River workers, doses between 5 and 10 rems
were associated with a threefold elevated risk, and doses over 10 rems were
associated with a fivefold elevated risk (33). None of the multiple myeloma
cases had recorded doses over the current U.S. occupational limit of five
rems per year.
From the United Kingdom comes evidence that paternal preconception exposures
are associated with risk of childhood cancer, stillbirth and an excess of
male compared to female births (34-36). The ability of radiation to induce
heritable genetic mutations in experimental animals has been recognized since
the 1920s (37). This recent evidence suggests that small doses of radiation
delivered in the period prior to conception can lead to genetic effects in
human offspring. Evidence on genomic instability following exposure to alpha
radiation
raises concerns for both carcinogenic and inherited genetic effects (38-40).
The belief that radiation risks at low doses could be extrapolated from high
dose studies led some to predict that cancer risks of radiation could not be
detected among nuclear workers. Although this has turned out to be false,
some researchers have pooled data from different worker populations in order
to increase sample size, believing that this would increase power to detect
radiation risks (41-43). Unfortunately, pooling populations with different
types of radiation, exposure conditions, measurement qualities and worker
selection factors, achieves statistical precision at the cost of accuracy,
diluting radiation effects (43).
Diseases and genetic mutations caused by radiation do not carry a marker
showing their origins, therefore epidemiologists look for excess rates of
disease in populations with higher radiation exposures. However, it is easy
to design an epidemiological study of environmental or occupational radiation
exposure that is unable to detect low level effects. Only in special
circumstances, such as the cases of well-monitored workers and certain
medical exposures (44), is it possible to quantify low doses and subsequent
risk. The sensitivity of epidemiological studies is compromised because
people generally cannot be traced between the time they are exposed and the
time disease develops, and because medical information (other than cause of
death) is not routinely available for populations without universal medical
care. It is incorrect to conclude that low level radiation is safe on the
basis of studies that lack careful radiation measurements and follow-up of
medical outcomes. Unfortunately such conclusions have been made based on
studies of geographic variation in average
background radiation (45).
Furthermore, some scientists have mistakenly claimed that there is no
evidence of radiation health effects below some arbitrary level. Not only do
such statements ignore an extensive medical literature on in utero and
occupational radiation; they reflect a basic misunderstanding of how
epidemiology works. In order to detect the risks from a hazardous agent,
epidemiologists study a range of exposure levels. For example, we compare
lung cancer rates of never-smokers to rates among people who smoke less than
a pack a day, one pack a day, two packs a day, and three or more packs a
day. It would be incorrect to separate the data for people who smoke one
cigarette a day and declare that low levels of smoking are safe. Conclusions
about health effects of agents such as radiation and cigarettes should be
derived from data on a range of exposures.
The current state of knowledge: As knowledge about ionizing radiation has
grown, health effects have been
recognized from activities that until recently were thought to be safe.
Despite past assurances about the safety of nuclear weapons tests, the
National Cancer Institute's recent study indicates that tens of thousands of
Americans can expect to get thyroid cancer from just one of the radionuclides
released by atmospheric testing (46). The fact that radiation protection
standards have been reduced as scientific study of low doses increases is
another measure of concern (7). Although the International Commission on
Radiation Protection recommended in 1990 that the 5 rem per year limit for
nuclear workers be reduced to 2, the U.S. continues to permit workers to be
exposed to more than twice the radiation dose allowed by countries that
adopted the international standard,
including Canada and the European Union.
The nuclear age is little more than a half-century old. Although much has
been learned about radiation during this time, there is much more that
remains to be understood about human health effects. It is increasingly
clear that there is great variability in the sensitivity of humans to low
level radiation due to factors such as age, genetic susceptibility and
exposures to chemical agents, infection or nutritional factors. Decisions
about exposure standards should take account of the special risks faced by
the young, the old and the genetically susceptible. Public health and moral
principles demand that we protect the most vulnerable.
As amply documented by the Secretarial Panel for the Evaluation of
Epidemiologic Research appointed by Admiral Watkins (47), President Clinton's
Advisory Committee on Human Radiation Experiments (48), a taskforce of the
Physicians for Social Responsibility (49), and numerous publications in the
scientific
literature (50-54), the body of scientific knowledge about the health effects
of ionizing radiation has been compromised by concerns about secrecy and
public relations. In its 1995 report, the President's Advisory Committee on
Human Radiation noted that, "By the mid-1960s the possibility that data
gathering could only get the AEC (Atomic Energy Commission) into more trouble
became an incentive to 'not study at all'" (48). These attitudes have
continued to affect research in recent decades (51, 52). In the case of
regulatory standards
that are intended to protect the health of workers and the public, policy
makers should consider scientific evidence and testimony with the
understanding that scientists have been restrained from fully investigating
the effects of low level ionizing radiation.
Current radiation standards already fail to adequately protect workers and
the public, even if flawed risk estimates from A-bomb studies are used: The
1994 GAO report on Nuclear Health and Safety notes that exposures permitted
by current Nuclear Regulatory Commission and Department of Energy guidelines,
according to those agencies, would lead to 1 in 300 premature cancer deaths
in the general public and 1 in 8 among workers (55). No other carcinogens
are permitted such lax standards. I strongly urge members of Congress and
the regulatory agencies to exercise precaution and prudence in order to
protect the health and lives of the public and of future generations who will
be affected by decisions on production and disposition of nuclear materials.